4 Analysts Assess OncoCyte: What You Need To Know
4 Analysts Assess OncoCyte: What You Need To Know
4 位分析師評估 OncoCyte：你需要知道的
Analysts' ratings for OncoCyte (NASDAQ:OCX) over the last quarter vary from bullish to bearish, as provided by 4 analysts.
4位分析師提供的分析師對OncoCyte（納斯達克股票代碼：OCX）在上個季度的評級從看漲到看跌不等。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表總結了他們最近的評級，展示了過去30天內不斷變化的情緒，並將其與前幾個月進行了比較。
Analysts have set 12-month price targets for OncoCyte, revealing an average target of $4.38, a high estimate of $5.00, and a low estimate of $4.00. This upward trend is evident, with the current average reflecting a 21.67% increase from the previous average price target of $3.60.
分析師已經爲OncoCyte設定了12個月的目標股價，顯示平均目標股價爲4.38美元，最高估計爲5.00美元，低估值爲4.00美元。這種上升趨勢顯而易見，當前的平均價格較之前的平均目標價3.60美元上漲了21.67％。
Investigating Analyst Ratings: An Elaborate Study
調查分析師評級：一項詳盡的研究
A comprehensive examination of how financial experts perceive OncoCyte is derived from...
對金融專家如何看待Onc...
登入免費觀看全文
登入/註冊